Clinical Trial Update: Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054) [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing desloratadine, fexofenadine 180 mg, and placebo for seasonal allergic rhinitis. The study assessed efficacy and safety and ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Desloratadine (desloratadine)
• Fexofenadine (fexofenadine)

Snippet

Sponsor: Organon and Co | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED